LITERATURE


Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic. Sharma D et al. J Neurosurg Anesthesiol April 2020, 8


Neurologic Manifestations of hospitalised patients with COVID-19 Hu B et al. JAMA Neurol April 2020, 10
Sudden and complete olfactory loss function as a possible symptom of COVID-19. Eliezer M et al. JAMA Otolaryngol Head Neck Surgery April 2020, 8
Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists J Huijuan et al. Stroke and Vasc Neurol April 2020, 1
Neurologic Manifestation of Hospitalised Patients with COVID-19 in Wuhan, China: a retrospective case series study Mao L et al. Lancet Neurology Mar 2020, 2
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients Li Y-C et al. J of Med Virology 2020 Feb, 27
Neurologic complications of coronavirus infections A Nath et al.
COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features N Poyiadji et al. Radiology Mar 2020, 31
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? M Desforges et al. Viruses Dec 2019, 20
Neurologic Alterations Due to Respiratory Virus Infection K Bohmwald et al. Front Cell Neurosci Oct 2018, 26
Neurosurgery during the COVID-19 pandemic: update from Lombardy, northern Italy C Zoia et al. Acta Neurochir March 2020, 28
Preparing a neurology department for SARS-CoV-2 (COVID-19): Early experiences at Columbia University Irving Medical Center and the New York Presbyterian Hospital in New York City G Waldman et al. Neurology April 2020, 6
Ethics in the time of COVID: What remains the same and what is different YHK Scott et al. Neurology April 2020, 6
On being a neurologist in Italy at the time of COVID-19 Outbreak A Bersano et al. Neurology April 2020, 3

Coronavirus seems to reach the brain. What could this mean for us?

From loss of smell to stroke, people with covid-19 are reporting strange neurological issues that challenge our understanding of the disease – and how to treat it

https://www.newscientist.com/article/mg24632842-800-coronavirus-seems-to-reach-the-brain-what-could-this-mean-for-us/

Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 A Review

https://jamanetwork.com/journals/jamaneurology/articlepdf/2766766/jamaneurology_zubair_2020_rv_200003.pdf


RESEARCH


NIHR Urgent Public Health Research Studies for COVID-19

RaDAR COVID-19:
The Association of British Neurologists aim to track suspected neurological complications of COVID-19 infection.
NeuroCritical Care Society COVID 19 OUTCOMES:
This study is a prospective cohort observational study to determine the impact of COVID 19 crisis on resource allocation and outcomes of ICU patients with acute neurological injury who require routine care and are not necessarily COVID 19 positive. The study will evaluate mortality and functional outcomes at hospital discharge and 90 days among critically ill, neurologically impaired patients admitted during the COVID 19 crisis period. Participating sites have the option to also compare those outcomes to a historical control group who were treated prior to the COVID 19 crisis.
NeuroCritical Care Society COVID 19 MANIFESTATIONS:
This study is a prospective observational cohort study to document prevalence and severity of neurological symptoms among patients with confirmed or suspected novel coronavirus (COVID 19). This study contains common data elements that all sites are requested to obtain (Tier 1 data), as well as supplemental data elements that are optional for sites to obtain retrospectively based on time and resources. This study will also offer optional addendums to investigate Tier 2 and Tier 3 strategies, such as more invasive blood and tissue sampling, based on local resources.
IctalGroup Neuro-COVID-19 Acute Encephalopathy in Critically Ill Patients With SARS-Cov-2 Infection:
We propose a prospective observational multicentre study which aim at reporting the prevalence of acute encephalopathy in critically ill patients with SAR-Cov-2 infection, to report related-outcomes and to identify prognostic factors.